436 related articles for article (PubMed ID: 25730525)
1. Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.
Voss EA; Ryan PB; Stang PE; Hough D; Alphs L
Int Clin Psychopharmacol; 2015 May; 30(3):151-7. PubMed ID: 25730525
[TBL] [Abstract][Full Text] [Related]
2. Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching.
Watanabe T; Yamada A
Psychopharmacol Bull; 2016 Aug; 46(2):42-52. PubMed ID: 27738379
[TBL] [Abstract][Full Text] [Related]
3. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens.
Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197
[TBL] [Abstract][Full Text] [Related]
4. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.
Song X; El Khoury AC; Brouillette M; Smith D; Joshi K
J Med Econ; 2019 Nov; 22(11):1105-1112. PubMed ID: 31062998
[No Abstract] [Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
Limosin F; Belhadi D; Comet D; Pacou M; Bouju S; Van Impe K; Guillon P
J Clin Psychopharmacol; 2018 Feb; 38(1):19-26. PubMed ID: 29232310
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.
Joshi K; Pan X; Wang R; Yang E; Benson C
Curr Med Res Opin; 2016 Nov; 32(11):1873-1881. PubMed ID: 27479694
[TBL] [Abstract][Full Text] [Related]
8. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
Tempest M; Sapin C; Beillat M; Robinson P; Treur M
J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
[TBL] [Abstract][Full Text] [Related]
10. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
11. Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics.
Schreiner A; Bergmans P; Cherubin P; Keim S; Llorca PM; Cosar B; Petralia A; Corrivetti G; Hargarter L
J Psychopharmacol; 2015 Aug; 29(8):910-22. PubMed ID: 25999398
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
[TBL] [Abstract][Full Text] [Related]
13. Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable.
Duncan EJ; Woolson SL; Hamer RM
Int Clin Psychopharmacol; 2012 Sep; 27(5):283-90. PubMed ID: 22644368
[TBL] [Abstract][Full Text] [Related]
14. Noninterventional, Naturalistic, Retrospective Study to Describe Prescription Patterns of Long-Acting Injectable Antipsychotics and the Impact of Introducing a New Atypical Antipsychotic in the Spanish Province of Tarragona Catchment Area.
Gaviria AM; Franco J; Rico G; Muntané G; Sáez C; Sánchez-Gistau V; de Pablo J; Vilella E
Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28346773
[TBL] [Abstract][Full Text] [Related]
15. Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.
Gaebel W; Schreiner A; Bergmans P; de Arce R; Rouillon F; Cordes J; Eriksson L; Smeraldi E
Neuropsychopharmacology; 2010 Nov; 35(12):2367-77. PubMed ID: 20686456
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics.
Xiao Y; Muser E; Fu DJ; Lafeuille MH; Pilon D; Emond B; Wu A; Duh MS; Lefebvre P
Curr Med Res Opin; 2016; 32(4):759-69. PubMed ID: 26750639
[TBL] [Abstract][Full Text] [Related]
17. Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study.
Miller BJ; Claxton A; Du Y; Weiden PJ; Potkin SG
Schizophr Res; 2019 Jun; 208():44-48. PubMed ID: 30745067
[TBL] [Abstract][Full Text] [Related]
18. Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder.
Yan T; Greene M; Chang E; Touya M; Broder MS
J Comp Eff Res; 2018 Nov; 7(11):1083-1093. PubMed ID: 30129771
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study.
Cai Q; Patel C; Kim E; Connolly N; Tunceli O; El Khoury AC
Adv Ther; 2019 Apr; 36(4):858-869. PubMed ID: 30848442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]